Anergis Investors
Anergis discovers and develops allergy vaccines based on the technology of Contiguous Overlapping Peptides for ultra-fast desensitization.
Connections
Industry:
Advanced Longevity (R&D)
Headquarters:
Vaud
Investor Type:
Healthcare Company
Founded Date:
2001
Employee Number:
1-10